These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 15650381

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Experimental study on the efficacy of combinations of glycopeptides and beta-lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides.
    Domenech A, Ribes S, Cabellos C, Taberner F, Tubau F, Domínguez MA, Montero A, Liñares J, Ariza J, Gudiol F.
    J Antimicrob Chemother; 2005 Oct; 56(4):709-16. PubMed ID: 16120625
    [Abstract] [Full Text] [Related]

  • 3. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, Jarvis WR.
    N Engl J Med; 1999 Feb 18; 340(7):493-501. PubMed ID: 10021469
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Experimental study of the efficacy of linezolid alone and in combinations against experimental meningitis due to Staphylococcus aureus strains with decreased susceptibility to beta-lactams and glycopeptides.
    Cabellos C, Garrigós C, Taberner F, Force E, Pachón-Ibañez ME.
    J Infect Chemother; 2014 Sep 18; 20(9):563-8. PubMed ID: 24973908
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative activity of tedizolid and glycopeptide combination therapies for the treatment of Staphylococcus aureus infections: an in vitro and in vivo evaluation against strains with reduced susceptibility to glycopeptides.
    Betts JW, Abdul Momin HF, Phee LM, Wareham DW.
    J Med Microbiol; 2018 Feb 18; 67(2):265-271. PubMed ID: 29300156
    [Abstract] [Full Text] [Related]

  • 9. [Searching for Staphylococcus aureus strains with reduced susceptibility to glycopeptides among clinical isolates obtained during the year of 2002].
    Młynarczyk A, Młynarczyk G, Łuczak M.
    Med Dosw Mikrobiol; 2003 Feb 18; 55(3):209-17. PubMed ID: 14702662
    [Abstract] [Full Text] [Related]

  • 10. Activities of LY333328 and vancomycin administered alone or in combination with gentamicin against three strains of vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model.
    Aeschlimann JR, Allen GP, Hershberger E, Rybak MJ.
    Antimicrob Agents Chemother; 2000 Nov 18; 44(11):2991-8. PubMed ID: 11036011
    [Abstract] [Full Text] [Related]

  • 11. Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.
    Cartolano GL, Cheron M, Benabid D, Leneveu M, Boisivon A, Association of Hospital Bacteriologists, Virologists and Hygiene Professionals.
    Clin Microbiol Infect; 2004 May 18; 10(5):448-51. PubMed ID: 15113324
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin.
    Climo MW, Patron RL, Archer GL.
    Antimicrob Agents Chemother; 1999 Jul 18; 43(7):1747-53. PubMed ID: 10390234
    [Abstract] [Full Text] [Related]

  • 14. Glycopeptide-intermediate Staphylococcus aureus: evaluation of a novel screening method and results of a survey of selected U.S. hospitals.
    Hubert SK, Mohammed JM, Fridkin SK, Gaynes RP, McGowan JE, Tenover FC.
    J Clin Microbiol; 1999 Nov 18; 37(11):3590-3. PubMed ID: 10523558
    [Abstract] [Full Text] [Related]

  • 15. Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy.
    Asseray N, Jacqueline C, Le Mabecque V, Batard E, Bugnon D, Potel G, Caillon J.
    Antimicrob Agents Chemother; 2005 Feb 18; 49(2):857-9. PubMed ID: 15673789
    [Abstract] [Full Text] [Related]

  • 16. Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals.
    Nonhoff C, Denis O, Struelens MJ.
    Clin Microbiol Infect; 2005 Mar 18; 11(3):214-20. PubMed ID: 15715719
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative analysis and validation of different assays for glycopeptide susceptibility among methicillin-resistant Staphylococcus aureus strains.
    Bernard L, Vaudaux P, Rohner P, Huggler E, Armanet M, Pittet D, Lew DP, Schrenzel J.
    J Microbiol Methods; 2004 May 18; 57(2):231-9. PubMed ID: 15063063
    [Abstract] [Full Text] [Related]

  • 19. Antibiotic resistance in Staphylococcus aureus and its relevance in therapy.
    Bal AM, Gould IM.
    Expert Opin Pharmacother; 2005 Oct 18; 6(13):2257-69. PubMed ID: 16218886
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.